Residency Program Update
Thomas J. Cummings, MD, Residency Program Director, announced that Rex Bentley, MD, is stepping down as Associate Residency Program Director.
Dr. Cummings Presents at Ophthalmic Pathology Event
Thomas J. Cummings, MD, presented at a recent Verhoeff-Zimmerman Ophthalmic Pathology Society (VZS) meeting on the topic of orbital Rosai-Dorfman disease and sarcoidosis.
Dr. Pavlisko Presents at AST Summit
The week of April 6-8, 2022, Elizabeth Pavlisko, MD, presented virtually at the American Society of Transplantation’s (AST) Cutting Edge of Transplantation’s (CEoT) Transplant Summit 2022: Defining success in organ transplantation meeting.
Dr. Glass Presents at Washington University Symposium
Carolyn Glass, MD, PhD, gave a presentation titled “Common Cardiovascular Findings in Autopsy Pathology” at a recent educational symposium focused on autopsy pathology sponsored by the Department of Pathology at Washington University in St. Louis, MO.
Welcome New Pathologists' Assistant Program Class
We are thrilled to welcome our new Pathologists' Assistant Program Class of 2024!
Dr. Huang Featured Speaker at Largest Cancer Conference in the World
Jiaoti Huang, MD, PhD, chaired the Educational Session, “Pathology for Cancer Researchers,” at the annual American Association for Cancer Research conference in New Orleans on Sat., April 9.
Dr. Ruhan Wei Joins Faculty
We’re thrilled to announce that Ruhan Wei, PhD, is joining our faculty as an Assistant Professor in the Department of Pathology.
Welcome 2022 Chief Residents
Please join us in welcoming Dr. Megan Lee and Dr. Kristen Logan, who will serve as Chief Residents for the 2022-2023 academic year!
Emily Hatheway Selected as Society of '67 Kinney Scholar
Emily Hatheway, MS3, has been selected as a 2022 Society of '67 Kinney Scholar.
Dr. Wang's Proposal Awarded Funding
Shih-Hsiu “Jerry” Wang, MD, has written a proposal titled “Novel pathogenic mechanisms linking age-related TDP-43 pathology, cerebrovascular pathology, and Alzheimer’s disease in the aging brain” that has been selected to receive $75,000 in funding per year for two years as a Duke/UNC Alzheimer’s Disease Research Center (ADRC) Developmental Project.